# Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)

> **NCT02193971** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 3429 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DEVICE:** BS-DES (Biostable polymer drug-eluting stent)
- **DEVICE:** BD-DES (Biodegradable polymer drug-eluting stent)
- **DRUG:** Prasugrel 5mg

## Key facts

- **NCT ID:** NCT02193971
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2020-10
- **Final completion:** 2024-01
- **Target enrollment:** 3429 (ACTUAL)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02193971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02193971, "Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02193971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*